Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 (Q90744909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

review article

3 references

13 July 2022

22 October 2022

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

1 reference

1 reference

Guangyu Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Qi Zhao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

publication date

15 March 2020

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

13 July 2022

22 October 2022

International Journal of Biological Sciences

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

13 July 2022

22 October 2022

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

1718-1723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

16 April 2020

copyright license

2 references

13 July 2022

22 October 2022

1 reference

12 December 2020

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus

1 reference

12 December 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

1 reference

12 December 2020

Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection

1 reference

12 December 2020

Use of convalescent plasma therapy in SARS patients in Hong Kong

1 reference

12 December 2020

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

12 December 2020

Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.

1 reference

12 December 2020

A human SARS-CoV neutralizing antibody against epitope on S2 protein

1 reference

12 December 2020

Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection

1 reference

12 December 2020

Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11.

1 reference

12 December 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

12 December 2020

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

1 reference

12 December 2020

SARS coronavirus and innate immunity

1 reference

12 December 2020

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

1 reference

12 December 2020

Disappearance of antibodies to SARS-associated coronavirus after recovery

1 reference

12 December 2020

Interferon and cytokine responses to SARS-coronavirus infection

1 reference

12 December 2020

Affinity maturation of antibodies assisted by in silico modeling.

1 reference

12 December 2020

Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses

1 reference

12 December 2020

Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential

1 reference

12 December 2020

Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits

1 reference

12 December 2020

Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing

1 reference

12 December 2020

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.

1 reference

12 December 2020

Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8

1 reference

12 December 2020

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

1 reference

12 December 2020

Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential

1 reference

12 December 2020

Understanding the T cell immune response in SARS coronavirus infection

1 reference

12 December 2020

Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques.

1 reference

12 December 2020

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

1 reference

12 December 2020

Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives

1 reference

12 December 2020

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

1 reference

12 December 2020

Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.

1 reference

12 December 2020

Human monoclonal antibodies as candidate therapeutics against emerging viruses

1 reference

12 December 2020

Screening and expressing HIV-1 specific antibody fragments in Saccharomyces cerevisiae

1 reference

12 December 2020

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

1 reference

12 December 2020

Coronavirus envelope protein: current knowledge

1 reference

12 December 2020

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China

1 reference

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

12 December 2020

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

1 reference

12 December 2020

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

1 reference

12 December 2020

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

1 reference

12 December 2020

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

1 reference

12 December 2020

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

12 December 2020

A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome

1 reference

12 December 2020

[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]

1 reference

12 December 2020

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

1 reference

12 December 2020

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

1 reference

12 December 2020

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

1 reference

12 December 2020

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

1 reference

12 December 2020

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

12 December 2020

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China

1 reference

12 December 2020

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJBS.45123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 April 2020

COVIDWHO ID

covidwho-24920

0 references

1125816938

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226289%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

PubMed publication ID

32226289

1 reference